¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 

#ÀÎõ°ú¹Î¼º¹æ±¤, #ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°, #ÀÎõ¹æ±¤¿°, #°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°ÇÑÀÇ¿ø, #ÀÎõ¹æ±¤¿°, #±¸¿ùµ¿°ú¹Î¼º¹æ±¤ 

 

 

ÀÎõ°ú¹Î¼º¹æ±¤,,ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°,,ÀÎõ¹æ±¤¿°,,°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°ÇÑÀÇ¿ø,,ÀÎõ¹æ±¤¿°,,±¸¿ùµ¿°ú¹Î¼º¹æ±¤

¾È³çÇϼ¼¿ä. ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä

 

 

ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹æ±¤¿°, °£Áú¼º¹æ±¤, ¼ºÀξߴ¢Áõ, ¹æ±¤¿°Ä¡·á, ¾ß´¢Áõ, ÀÜ´¢°¨, ¿©Àڹ汤¿°Áõ»ó, °£Áú¼º¹æ±¤¿°, ³²ÀÚÀÜ´¢°¨, ºÓÀº¼Òº¯, ¿©¼ºÀÜ´¢°¨, ¼Òº¯Ç÷´¢, ³²Àڹ汤¿°, Áú¿°ÀÜ´¢°¨, ¾î¸°ÀÌ¿ÀÁܼÒÅÂ, ÀÓ½ÅÁß¿ÀÁܼÒÅÂ, ¿ä½Ç±Ý, ¼Ò¾Æ¹æ±¤¿°, Àý¹Ú´¢, °ú¹Î¼º¹æ±¤, ¿©Àڹ财Åë, ºó´¢, Àü¸³¼±, ¹æ±¤¿°¼Òº¯, ¸¸¼º¹æ±¤¿°µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.

 

 

¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, ¼ÒÇÕÇâ¿ø, ¿Â¿­Ä¡·á, ¸¶»çÁö, ±ÙÀ̿Ͼàħ, ¾îÇ÷¾àħ, ¸Å¼±¿ä¹ý, µµÀο¿ä¹ý, ÁßdzÁ¶±â°ËÁø, Çâ±â¿ä¹ý, ´Ü¼ø¿îµ¿Ä¡·á, ½½¸µ, ·Ñ¸µ, ³Ã¿Â¿å, mechanical therapy, paraffin, Àü±âÀÚ±ØÄ¡·á, Çdz»Ä§, ü¿­Áø´Ü±â, ¾Æ·Î¸¶Å׶óÇÇ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù

 

 

¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê »çÇϱ¸ ´Ù´ë1µ¿, Àü³² ¿©¼ö½Ã °øÈ­µ¿, ¿ï»ê ºÏ±¸ »êÇϵ¿, Àü³² ±¸·Ê±º ±¤ÀǸé, °æ³² ÀǷɱº Ä¥°î¸é, ÀüºÏ ÀÍ»ê½Ã ÆȺÀµ¿, ÀÎõ °è¾ç±¸ µ¿¾çµ¿, ºÎ»ê ±ÝÁ¤±¸ ȸµ¿µ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æ³² ±èÇؽà ¾î¹æµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »ó³²µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿3°¡, ÃæºÏ ÃæÁֽà ÁÖ´öÀ¾, °æºÏ ¹®°æ½Ã »ê¾ç¸é, Àü³² ¸ñÆ÷½Ã ÃøÈĵ¿, °æ³² °ÅÁ¦½Ã °ÅÁ¦¸é, ¿ï»ê Áß±¸ ¿Á±³µ¿, °­¿ø °­¸ª½Ã ȸ»êµ¿, Àü³² ¸ñÆ÷½Ã Ãູµ¿1°¡, °æ±â ¾È¼º½Ã ±Ý¼®µ¿, ºÎ»ê ºÏ±¸ È­¸íµ¿, Àü³² ³ªÁֽà »ï¿µµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ºÈ£µ¿, °­¿ø ö¿ø±º ±Ù³²¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, Àü³² ¿µ±¤±º ´ë¸¶¸é, °æ³² »çõ½Ã À̱ݵ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ »ïõµ¿2°¡, ¿ï»ê ºÏ±¸ ´Þõµ¿, ÀÎõ °­È­±º ¾ç»ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù

 

 

ÀÎõ°ú¹Î¼º¹æ±¤Ä¡·á ãÀ¸½Ã´Â ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, ûÇе¿, ¿ëÇöµ¿, µ¿ÀÎõ, ¼þÀǵ¿, À²¸ñµ¿, °è¾ç±¸, ¿ëÀ¯µµ, °¡Á¤µ¿, °£¼®µ¿, ³íÇö°íÀܵ¿, ¼Û¸²µ¿, ºÎõ, µ¿±¸, Áßµ¿, °ü±³µ¿, Á־ȿª, °Ë¾Ï, ¿µÁ¾Çϴõµ½Ã, ¼Ò·¡Æ÷±¸, ³²µ¿±¸, °¡Áµ¿, ºñºÀ¸é, µµ¸²µ¿, ÀÎõÁÖ¾È, ³²¾çÀ¾, ¹®Çе¿, ÀÎõ, ¼±Çе¿, ÀÎõ³íÇö, ¹è°ð, ±¸¿ùµ¿, ¼Ûµµ±¹Á¦µµ½Ã, Áß±¸ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.

 

´õ »ìÆ캸±â

 

1. Gammie A, Kaper M, Dorrepaal C, et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol 2016; 69:361.

2. Herzog AR, Diokno AC, Brown MB, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 1994; 42:264.

3. Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J 2017; 28:687.

4. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003; 188:S77.

5. Milson I, Altman D, Lapitan, et al.. Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd., Plymouth, UK 2009. p.35.

6. Robinson D, Hanna-Mitchell A, Rantell A, et al. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017; 36:876.

7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101:1388.

8. www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf (Accessed on April 06, 2015).

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û õȣ¿ª ÇÏ´ÃüÇÑÀÇ¿ø 10¿ù ´Üµ¶¾ÞÄÝÀ̺¥Æ®
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
612 7¿ù À̺¥Æ® Á¸½ºÅ²ÇÑÀÇ¿ø ÀÏ»êÁ¡ ¿©µå¸§6ÁÖÇÁ·ÎÁ§Æ® 0 1,120 2019-07-12
611 µµ°îÇÑÀÇ¿ø 2 1,072 2019-07-09
610 Àß³ª°¡´ÂÇÑÀÇ¿ø - ±¸¸®Ä¡Áú ÇÑÀÇ¿ø Ưº°À̺¥Æ® Àâ±â 0 1,953 2019-07-05
609 È­Á¢¸ùÇÑÀÇ¿ø 2019³â 7¿ù ¿©¸§ ¹Ùµð À̺¥Æ® 0 1,190 2019-07-02
608 Á¤À̾ÈÇÑÀÇ¿ø 7¿ù ÇÑ´Þ°£ Ãâ½Ã±â³äÀ̺¥Æ® - ÁöÄ£¿©¸§¿£ ±â·Âº¸°­À» À§.. 0 1,195 2019-07-02
607 ¹Ý¿ù´ç ¶óÀ²ÇÑÀÇ¿ø 7¿ù ÇÖÇÑ ¿©¸§À» À§ÇÑ ¸¶Áö¸· Áغñ! 0 680 2019-07-02
606 º½º½ÇÑÀÇ¿ø 7¿ù À̺¥Æ® ¨ç [Çѹ濬°í ÀÚ¿î°í] 0 1,380 2019-07-02
605 7¿ù ÂüÇÑÀÇ¿ø °æ¿Á°í, °æ¿Áȯ ÇÒÀÎ À̺¥Æ® 0 1,149 2019-06-30
604 [´ëÀüµÐ»êµ¿´Ù³ªÇÑÀÇ¿ø] 7¿ù ¸¶±×³×ƽ ü¾î À̺¥Æ® 1 2,404 2019-06-30
603 ¸íµ¿±Ô¸²ÇÑÀÇ¿ø 6¿ù ¿©¸§À̺¥Æ® 0 876 2019-06-14
602 ¿©¸§ÀÇ ½ÃÀÛ, 6¿ùµµ ½Å¼ö¸²ÇÑÀÇ¿ø ¾ÈƼ¿¡ÀÌ¡ Ä¡·á¿Í ÇÔ²²Çϼ¼¿ä(feat... 0 1,301 2019-06-14
601 6¿ù ûÁÖ ±Ô¸²ÇÑÀÇ¿ø À̺¥Æ® 0 1,291 2019-06-14
600 [È­Á¤¿ª È¿ÀçÇÑÀÇ¿ø]6¿ù À̺¥Æ® 0 2,540 2019-06-14
599 ÂüÇÑÀÇ¿ø 6¿ù ÇÒÀÎ À̺¥Æ® 0 626 2019-06-03
598 2019³â 6¿ù ¹Ùµð À̺¥Æ®- È­Á¢¸ùÇÑÀÇ¿ø 0 738 2019-05-31
597 ÁöÀ½ÇÑÀÇ¿ø ¿©¸§¸ÂÀÌ À̺¥Æ® 0 904 2019-05-31
596 [¸®»ùÇÑÀÇ¿ø ÀÏ»êÁ¡]6¿ùÀ̺¥Æ® 0 932 2019-05-31
595 [µÐ»êµ¿´Ù³ªÇÑÀÇ¿ø6¿ùÀ̺¥Æ®] µÐ»êµ¿ ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ´Ù³ª¿Í ÇÔ²² ÀÚ.. 1 1,743 2019-05-31
594 ¸¶»ê¼Û¸²ÇÑÀÇ¿ø - °¨»çÀÇ ´Þ 5¿ù ÇÒÀÎ À̺¥Æ® 0 1,509 2019-05-08
593 ºÎ»ê´ÙÀ̾îÆ® ÇÑÀÇ¿ø -5¿ù À̺¥Æ® 0 1,200 2019-05-08
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷